Statement of Principles concerning malignant neoplasm of the liver No. 171 of 1996

Administered by Department of Veterans' Affairs

Legislation au F2008B00598 Not in force Legislative Instrument

Legislation content

Instrument No.171 of 1996

 

Revocation and Determination

of

Statement of Principles

concerning

 

MALIGNANT NEOPLASM OF THE LIVER

 

ICD CODE: 155.0

 

Veterans’ Entitlements Act 1986

 

 

1. The Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act):

 

(a) revokes Instrument No.33 of 1995, and Instrument No.271 of 1995; and

 

(b) determines the following Statement of Principles.

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about malignant neoplasm of the liver and death from malignant neoplasm of the liver.

 

(b) For the purposes of this Statement of Principles, “malignant neoplasm of the liver” means a primary malignant tumour arising from  the cells of the liver, attracting ICD code 155.0.

 

Note: This definition specifically excludes soft tissue sarcoma, non-Hodgkin's lymphoma and Hodgkin's disease.

 

Note to user (this note does not form part of the legal wording of the instrument):

 

In the event that a disease referred to in the note above (which is excluded from coverage by this Statement of Principles) is claimed, reference should be made to the relevant Statement of Principles (or Statements of Principles) which cover or refer to that disease (if any).

 

Basis for determining the factors

3. The Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that malignant neoplasm of the liver and death from malignant neoplasm of the liver can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces.

 

Factors that must be related to service

4. Subject to clause 6, the factors set out in at least one of the paragraphs in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5. The factors that must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the liver or death from malignant neoplasm of the liver with the circumstances of a person’s relevant service are:

 

(a) for hepatocellular carcinoma only:

 

(i) suffering hepatitis B infection with evidence of chronicity before the clinical onset of malignant neoplasm of the liver; or

 

(ii) suffering from hepatitis C infection before the clinical onset of malignant neoplasm of the liver; or

 

(iii) suffering from cirrhosis of the liver before  the clinical onset of malignant neoplasm of the liver; or

 

(iv) consuming at least 150 kg of alcohol (contained within alcoholic drinks) within any ten year period before the clinical onset of malignant neoplasm of the liver; or

 

(v) smoking at least ten pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of malignant neoplasm of the liver, and, where smoking has ceased, the clinical onset has occurred within ten years of cessation; or

 

(vi) being heavily exposed to aflatoxins for a period of at least ten years in the 20 years immediately before the clinical onset of malignant neoplasm of the liver; or

 

(b) inability to obtain appropriate clinical management for malignant neoplasm of the liver.

 

Factors that apply only to material contribution or aggravation

6. Paragraph 5(b) applies only to material contribution to, or aggravation of, malignant neoplasm of the liver where the person’s malignant neoplasm of the liver was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e), 70(5)(d) or 70(5A)(d) of the Act refers.

 

Other definitions

7. For the purposes of this Statement of Principles:

 

“alcohol” consumption is measured using the Australian Standard of 10 grams absolute alcohol per standard alcoholic drink;

 

being heavily exposed to aflatoxins” means consuming food containing high concentrations of aflatoxins at least four days per week, on average.  That the food had a high concentration of aflatoxins can be determined by biochemical measurement, or inferred from the prolonged storage of foodstuffs in humid conditions.  This typically may occur in storage of peanuts, rice or other grains in such regions as South East Asia;

 

“cirrhosis of the liver” means a pathologically defined entity involving irreversible chronic injury of the hepatic parenchyma, and includes extensive fibrosis in association with regenerative nodules.  It is characterised by diffuse interlacing bands of fibrous tissue typically dividing the hepatic parenchyma into micronodular or macronodular areas, attracting ICD code 571.2, 571.5 or 571.6;

 

“hepatitis B with evidence of chronicity” means evidence of such on serologic testing, ie the presence of HBsAg in the absence of IgM Anti-HBc, attracting ICD code 070.22, 070.23, 070.32 or 070.33;

 

“hepatitis C” means the presence of anti-HCV on serologic testing, attracting ICD code 070.41, 070.44, 070.51 or 070.54;

 

“hepatocellular carcinoma” means a primary carcinoma of hepatocytes, also known as primary liver cancer or hepatocarcinoma;

 

“ICD code” means a number assigned to a particular kind of injury or disease in the Australian Version of The International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM), effective date of 1 July 1996, copyrighted by the National Coding Centre, Faculty of Health Sciences, University of Sydney, NSW, and having ISBN 0 642 24447 2;

 

“pack-year” means 7 300 cigarettes, or 1 460 cigars, or 7.3 kg of pipe tobacco;

 

“relevant service” means:

 

(a) operational service; or

(b) peacekeeping service; or

(c) hazardous service.

 

Application

8. This Instrument applies to all matters to which section 120A of the Act applies.

 

 

Dated this Ninth day of  December  1996

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of:    )

KEN DONALD

CHAIRMAN

Overview

The Veterans' Entitlements Act 1986 was enacted to address the specific needs of veterans, members of Peacekeeping Forces, and members of the Forces in relation to their health and entitlements. This Act was introduced by the Australian Parliament to ensure that those who have served in the defence forces receive appropriate recognition and support for injuries and diseases sustained during their service. In 1996, the Repatriation Medical Authority, under the authority of the Act, revoked two previous instruments and determined a new Statement of Principles concerning malignant neoplasm of the liver and death from this condition. The policy objective behind this determination is to provide a clear framework for assessing the connection between the malignant neoplasm of the liver and the circumstances of a person’s relevant service, ensuring that veterans can receive the necessary support and recognition for their service-related health issues.

Scope and Application

The Legislative Instrument No.171 of 1996, under the Veterans’ Entitlements Act 1986, pertains specifically to the revocation and determination of Statements of Principles concerning malignant neoplasm of the liver, identified by ICD code 155.0. This legislation applies to veterans, members of Peacekeeping Forces, and members of the Armed Forces who have rendered relevant service, including operational, peacekeeping, or hazardous service. The scope of this instrument is confined to the revocation of previously issued Statements of Principles and the establishment of new criteria for determining the connection between malignant neoplasm of the liver and the service rendered by these individuals. Notably, this Statement of Principles explicitly excludes certain diseases such as soft tissue sarcoma, non-Hodgkin's lymphoma, and Hodgkin's disease. The instrument also delineates factors that must be related to the service, such as hepatitis B or C infections, cirrhosis of the liver, alcohol consumption, tobacco use, and exposure to aflatoxins, among others. The application of this legislation is determined by section 120A of the Act, and any subsequent amendments or extensions to its application would be made through subordinate instruments.

Key Provisions

The main operative sections of the legislative instrument (F2008B00598) concern the revocation of previous instruments and the determination of a new Statement of Principles regarding malignant neoplasm of the liver (section 1). This Statement of Principles specifies that the malignant neoplasm of the liver is a primary malignant tumour arising from the cells of the liver, with the ICD code 155.0, and it excludes soft tissue sarcoma, non-Hodgkin's lymphoma, and Hodgkin's disease (section 2). The instrument further outlines the medical-scientific evidence linking this condition to relevant service by veterans, members of Peacekeeping Forces, or members of the Forces (section 3). Additionally, it sets out the factors that must be related to service, with specific criteria for hepatocellular carcinoma and other related conditions (section 5). The obligations and requirements imposed by this Act on the parties or entities it governs include the necessity for the relevant service of a veteran or member to be connected to certain specified factors, such as chronic hepatitis B or C infections, cirrhosis of the liver, or heavy exposure to aflatoxins, among others (section 5). This ensures that a reasonable hypothesis can be raised connecting the malignant neoplasm of the liver or death from it with the circumstances of a person's relevant service. The instrument mandates that these factors must be related to any relevant service rendered by the person unless otherwise specified (section 4). The document also provides specific definitions for terms such as "alcohol" consumption, "cirrhosis of the liver," "hepatitis B with evidence of chronicity," and "hepatitis C," among others, to ensure clarity and consistency in application (section 7). Any offences, penalties, or civil/criminal consequences for breach are not explicitly stated in this legislative instrument. However, the overarching Veterans’ Entitlements Act 1986, under which this instrument operates, provides a framework for handling breaches. Typically, breaches of such legislative instruments may lead to administrative actions, which could include fines or other administrative penalties. Given that this instrument is more focused on the determination of medical-scientific evidence and the setting out of conditions for entitlements, it primarily serves an informative and regulatory purpose rather than penalising non-compliance directly. Nonetheless, the implications of failing to meet the outlined criteria could affect eligibility for veterans’ entitlements.

Legal classification tags

Area of Law
Veterans’ Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Reporting & Disclosure Obligations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.